- Home
- COE vs CATX Comparison
COE vs CATX Comparison
Compare COE & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COE | CATX |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.1M | 211.1M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | COE | CATX |
|---|---|---|
| Price | $26.20 | $4.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 5.5K | ★ 1.1M |
| Earning Date | 03-20-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,215,000.00 | $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.72 | N/A |
| 52 Week Low | $13.60 | $1.60 |
| 52 Week High | $56.13 | $5.39 |
Technical Indicators
Market Signals| Indicator | COE | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 34.17 | 74.20 |
| Support Level | $25.14 | $2.55 |
| Resistance Level | $26.51 | $2.78 |
| Average True Range (ATR) | 0.97 | 0.46 |
| MACD | 0.25 | 0.09 |
| Stochastic Oscillator | 20.80 | 45.91 |
Price Performance
Historical ComparisonAbout COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.